about
sameAs
Impact of Chronic HIV/SIV Infection on T Follicular Helper Cell Subsets and Germinal Center HomeostasisCTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitopeMacrophage plasticity in experimental atherosclerosis.HIV-1 and SIV Predominantly Use CCR5 Expressed on a Precursor Population to Establish Infection in T Follicular Helper Cells.Immune responses elicited in tertiary lymphoid tissues display distinctive featuresThe HIV-1 antisense protein (ASP) induces CD8 T cell responses during chronic infection.High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy.HIV-Infected Spleens Present Altered Follicular Helper T Cell (Tfh) Subsets and Skewed B Cell Maturation.Intravenous immunoglobulin: an update on the clinical use and mechanisms of action.HIV-Specific B Cell Frequency Correlates with Neutralization Breadth in Patients Naturally Controlling HIV-Infection.STEAP, a prostate tumor antigen, is a target of human CD8+ T cells.Triggering of TLR-3, -4, NOD2, and DC-SIGN reduces viral replication and increases T-cell activation capacity of HIV-infected human dendritic cells.Inducible Hsp70 as target of anticancer immunotherapy: Identification of HLA-A*0201-restricted epitopes.EphA2 as target of anticancer immunotherapy: identification of HLA-A*0201-restricted epitopes.HIV-Infected Dendritic Cells Present Endogenous MHC Class II-Restricted Antigens to HIV-Specific CD4+ T Cells.HER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapy.B Cells Loaded with Synthetic Particulate Antigens: A Versatile Platform To Generate Antigen-Specific Helper T Cells for Cell Therapy.A general strategy to optimize immunogenicity of HLA-B*0702 restricted cryptic peptides from tumor associated antigens: Design of universal neo-antigen like tumor vaccines for HLA-B*0702 positive patients.TCR stimulation drives cleavage and shedding of the ITIM receptor CD31.[Follicular helper T cells and HIV - United for better and worse].Magnetic Detection Structure for Lab-on-Chip Applications Based on the Frequency Mixing Technique.Intravenous Immunoglobulins in Autoimmune and Inflammatory Diseases: A Mechanistic PerspectiveChronic Rejection Triggers the Development of an Aggressive Intragraft Immune Response through Recapitulation of Lymphoid OrganogenesisGeneration of CTL recognizing an HLA-A*0201-restricted epitope shared by MAGE-A1, -A2, -A3, -A4, -A6, -A10, and -A12 tumor antigens: implication in a broad-spectrum tumor immunotherapyInduction of multiple CD8+ T cell responses against the inducible Hsp70 employing an Hsp70 oligoepitope peptideDistinct role for CD8 T cells toward cutaneous tumors and visceral metastasesAntiangiogenic treatment prevents adventitial constrictive remodeling in graft arteriosclerosisGerminal centers B-cell reaction and T follicular helper cells in response to HIV-1 infectionPresence of T cells directed against CD20-derived peptides in healthy individuals and lymphoma patients
P50
Q28077701-4E61B7F7-C7FD-4A55-A3CB-F22649E8A70BQ31010282-0450CD1E-ADB1-4724-B9BA-B7E11FDC52C4Q33527405-598024FD-82CA-44C0-88D6-07CCE9461C15Q33586177-F732839C-739C-41B8-9A9E-D5806F47F5E6Q33627619-B066A1A8-1D96-4A1D-B681-CDA5984C9463Q35105393-A8448BBA-0360-48DD-97E2-D743933BBB84Q35631830-B10E37F1-4BE3-47F6-84CC-472FD01F0A00Q35821193-C8038B22-0979-4E51-9FE0-221529109898Q36757383-C922E153-D1F2-4450-8C08-4805FC60C015Q40159913-A0D83C2F-006F-4E6A-AE5B-90F6DC7B8287Q40290496-C9711499-5FE1-43A1-A1C4-FC4F8F3DA36CQ40305499-41BD1097-1FAA-4887-8D2B-AEEE60BD3CB6Q40601130-2E254AEB-8590-4506-9000-EB6AF564DF1BQ40606759-6AF64F14-AD7F-4DC2-81BF-A3BA46FD300FQ40706800-F55EA5CC-BF4C-4EAB-AFB2-617118093119Q40730426-F982054A-D879-4023-9483-2A7EA541107AQ40877684-0AF5E891-D4A8-4E34-9B31-36A34BF8028EQ42031722-DF846CD9-FE51-4CED-B1C9-F8220A2B8708Q42750321-C5C1359C-F359-4873-9D0F-F842060FD0EFQ52469515-9BBE8336-B88B-442B-949A-CBCBF8B6E899Q55423969-7517244F-0322-4C3E-BED1-8523E93C62F1Q58864646-AABA6076-6EF6-491B-9A11-4324ADAC83CBQ59387561-F4FD10AB-D2A8-4B4D-99D1-4A9553B2A095Q74335031-31ACEEA5-2F8D-417E-B90F-BA440FD6C7E0Q79712635-F0CE7750-FAAD-4EAA-B8B3-F0E9338E7ADAQ80241859-76D1A0FA-FB58-4217-922A-4D7B6886D93BQ80532678-81A8FFB5-5210-49C8-8E90-DD7A32480ECEQ93150662-640D2CB8-A615-44D8-A6B3-856F65C55DC6Q93173226-81E9586B-57D7-4A83-9BA5-6236175C03A5
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Stéphanie Graff-Dubois
@ast
Stéphanie Graff-Dubois
@en
Stéphanie Graff-Dubois
@es
Stéphanie Graff-Dubois
@nl
type
label
Stéphanie Graff-Dubois
@ast
Stéphanie Graff-Dubois
@en
Stéphanie Graff-Dubois
@es
Stéphanie Graff-Dubois
@nl
prefLabel
Stéphanie Graff-Dubois
@ast
Stéphanie Graff-Dubois
@en
Stéphanie Graff-Dubois
@es
Stéphanie Graff-Dubois
@nl
P106
P21
P31
P496
0000-0001-7273-3930